temozolomide has been researched along with Allergic Bronchopulmonary Mycosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is an oral alkylating agent incorporated in the treatment of glioblastoma multiforme (GBM) that can lead to lymphopenia." | 5.12 | Temozolomide is a risk factor for invasive pulmonary aspergillosis: A case report and literature review. ( Brault, C; Chouaki, T; Maizel, J; Nyga, R; Zerbib, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brault, C | 1 |
| Zerbib, Y | 1 |
| Chouaki, T | 1 |
| Maizel, J | 1 |
| Nyga, R | 1 |
1 review available for temozolomide and Allergic Bronchopulmonary Mycosis
| Article | Year |
|---|---|
Temozolomide is a risk factor for invasive pulmonary aspergillosis: A case report and literature review.
Topics: Aged; Brain Neoplasms; Glioblastoma; Humans; Invasive Pulmonary Aspergillosis; Male; Risk Factors; T | 2021 |